Third edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

It’s our pleasure to share with you the third Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

ALLG News is for people, like you, who are interested in medical research and ALLG’s mission to create better treatments and better lives for patients with blood cancers.

Our teletrials allow greater access for patients living in rural and regional areas of Australia and New Zealander, to participate on clinical trials; including patients just like Cairns (Australia) resident Vesselin (Vess) Petkov who joined an ALLG clinical trial for the treatment of his Mantle Cell Lymphoma. You can read Vess’ story, and more, in this newsletter.

As the only non-profit collaborative clinical trials groups in Australia and New Zealand for blood cancers, the ALLG has the capability to run independent doctor-led clinical trials in Australasia and, crucially, to participate in teletrials and international trials; allowing us access to new treatments, with the potential to make a significant impact on patient outcome.

We hope you enjoy reading about ALLG’s world-leading blood cancer research and the impact your support has for patients with blood cancers. We look forward to sharing more news with you this year, which is the ALLG’s 50th Anniversary year!

You can read ALLG News Edition 3 here.

You can subscribe to future editions of ALLG News here.